Form 4 for SER Serina Therapeutics, Inc.
Accepted 2024-12-19 00:00:00 ET · period of report 2024-12-17 · accession 0001493152-24-050774 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-19 | 2024-12-17 | SER | Bailey Gregory | Dir | P - Purchase | $4.59 | +3,866 | 67.2K | +6% | +$17.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-17 | P | A | 3,866 | $4.59 | 67,243 | D | — | — | (F1) The price reflects the weighted average purchase price of multiple transactions ranging from a low of $4.54 per share to a high of $4.74 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price. |